Daniel Wei Lin
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 133
- Prostate Cancer Treatment and Research 88
- Renal cell carcinoma treatment 12
-
- Cancer, Lipids, and Metabolism 21
- Co-authors
- Peter Nelson (52 shared papers)Robert L. Vessella (13 shared papers)Beatrice S. Knudsen (6 shared papers)Jonathan Lawrence Wright (66 shared papers)Robert C. Gentleman (2 shared papers)Jennifer L. Noteboom (2 shared papers)Rachael K. Parkin (1 shared paper)Daniel B. Martin (1 shared paper)
- Journals
- The Journal of Urology (53 papers)The Prostate (20 papers)European Urology (19 papers)Urologic Oncology Seminars and Original Investigations (18 papers)Journal of Clinical Oncology (12 papers)
- Partner nations
- United StatesCanadaSouth Africa
In The Last Decade
Daniel Wei Lin
299 papers receiving 22.4k citations
Daniel Wei Lin's Hit Papers
Peers
Comparison fields: 5 of 175
- Cancer Research 6.9k
- Pulmonary and Respiratory Medicine 9.6k
- Molecular Biology 7.3k
- Urology 502
- Oncology 1.9k
Countries citing papers authored by Daniel Wei Lin
This map shows the geographic impact of Daniel Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wei Lin more than expected).
Fields of papers citing papers by Daniel Wei Lin
This network shows the impact of papers produced by Daniel Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wei Lin. The network helps show where Daniel Wei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Wei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 306 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circulating microRNAs as stable blood-based markers for cancer detection Hit paper breakdown → | 2008 | 6956 |
| 2 | Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy Hit paper breakdown → | 2007 | 714 |
| 3 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci Hit paper breakdown → | 2018 | 623 |
| 4 | Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers Hit paper breakdown → | 2018 | 490 |
| 5 | 2007 | 426 | |
| 6 | A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer Hit paper breakdown → | 2014 | 332 |
| 7 | Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2019 | 331 |
| 8 | 2019 | 321 | |
| 9 | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management Hit paper breakdown → | 2022 | 311 |
| 10 | 2019 | 291 | |
| 11 | 2017 | 273 | |
| 12 | Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening Hit paper breakdown → | 2023 | 239 |
| 13 | 2013 | 228 | |
| 14 | 2014 | 226 | |
| 15 | 2006 | 225 | |
| 16 | 2013 | 224 | |
| 17 | 2020 | 211 | |
| 18 | 2017 | 205 | |
| 19 | 2015 | 201 | |
| 20 | 2010 | 192 |
About Daniel Wei Lin
Daniel Wei Lin is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Surgery, Oncology and Urology, having authored 306 papers that have together received 22.9k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (133 papers), Prostate Cancer Treatment and Research (88 papers), Bladder and Urothelial Cancer Treatments (27 papers), Cancer, Lipids, and Metabolism (21 papers), Renal cell carcinoma treatment (12 papers), Testicular diseases and treatments (9 papers), Hormonal and reproductive studies (9 papers) and Genital Health and Disease (8 papers). The work is most often cited by research in Cancer Research (6.9k citations), Pulmonary and Respiratory Medicine (9.6k citations), Molecular Biology (7.3k citations), Urology (502 citations) and Oncology (1.9k citations). Daniel Wei Lin has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Peter Nelson, Robert L. Vessella, Beatrice S. Knudsen, Jonathan Lawrence Wright, Robert C. Gentleman, Jennifer L. Noteboom, Rachael K. Parkin, Daniel B. Martin, Muneesh Tewari and Amelia C. Peterson. Their work appears in journals such as The Journal of Urology, The Prostate, European Urology, Urologic Oncology Seminars and Original Investigations and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.